DRAP denies reports of price hike in essential medicines
- 29-Mar-2026
The Drug Regulatory Authority of Pakistan (DRAP) has rejected reports of a recent increase in the prices of essential medicines, describing them as baseless. A DRAP spokesperson stated that there has been no increase in the prices of insulin and other life-saving drugs. Pharmaceutical companies are not permitted to raise the prices of essential medicines […]
DRAP to ‘make’ raw material quotas of THESE medicines online to boost transparency
- 30-Dec-2025
Drug Regulatory Authority (DRAP) has decided to shift the allocation of raw material quotas for sedatives and painkiller medicines to an online system in Pakistan, ARY News reported on Tuesday, citing well-informed sources. According to sources, DRAP will now allocate quotas for controlled drugs’ raw materials through a digital platform, with the objective of ensuring […]
DRAP, CCP ink MoU to strengthen pharmaceutical oversight
- 27-Nov-2025
The Competition Commission of Pakistan (CCP) and the Drug Regulatory Authority of Pakistan (DRAP) have signed a memorandum of understanding to enhance cooperation between the two institutions. Under the MoU, both bodies will share information and data to improve regulatory oversight of the pharmaceutical market. According to details, the two authorities agreed to collaborate on […]
DRAP seizes fake medicines in nationwide crackdown
- 18-Sep-2025
ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) seized fake medicines in a nationwide crackdown, ARY News reported on Thursday. As per details, countrywide operations against counterfeit medicines are underway, with several batches of fake drugs seized from medical markets across Pakistan. According to DRAP, the confiscated medicines include treatments for fever, body pain, bacterial […]
DRAP issues warning on sale of counterfeit medicines’ batches
- 23-Aug-2025
ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has asked the public not to use specific batches of different medicines, declaring them as counterfeit. In a warning issued here, the DRAP has also released images of counterfeit medicines being sold in various parts of Punjab and Gilgit-Baltistan. These fake drugs include treatments for fever, body […]
DRAP issues alert as GSK voluntarily recalls Amoxil batch
- 06-Aug-2025
ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has issued an alert to recall Amoxil Suspension and Amoxil Forte Suspension due to quality defect. GlaxoSmithKline (GSK) Pakistan has initiated a voluntary recall of multiple batches of its widely used antibiotics — Amoxil Suspension and Amoxil Forte Suspension — following a quality concern related to defective […]
DRAP intensifies crackdown on counterfeit medicines
- 29-Mar-2025
ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has launched a nationwide campaign to combat the illegal sale, manufacturing, and distribution of spurious and counterfeit medicines, ARY News reported. Over the past 15 days, DRAP has conducted successful enforcement actions, resulting in substantial seizures, facility sealings, and legal proceedings, a press statement issued here read […]
DRAP seizes counterfeit medicines in Karachi
- 19-Feb-2025
Drug Regulatory Authority of Pakistan (DRAP) seized stock of counterfeit medicines of famous pharmaceutical companies in Karachi, ARY News reported on Wednesday. As per details, counterfeit medicines of well-known pharmaceutical companies were seized by the drug inspectors after the companies denied the batches of the medicines being sealed in Karachi. The Drug Testing Laboratory has […]
DRAP issues warning against THESE skin brightening injections
- 08-Feb-2025
ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has issued a warning about counterfeit skin brightening injections, ARY News reported. According to DRAP, Laroscorbine Platinum Injections are believed to brighten the skin and maintain skin elasticity, but the administration of counterfeit products can result in treatment failure, worsening of the disease, or life-threatening consequences. According […]
DRAP recalls batch of THIS medicine
- 03-Feb-2025
ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has suspended the use of Mirzpan Suspension and imposed a ban on its supply and sale, ARY News reported. According to details, after the discovery of the supply of counterfeit antibiotics in Balochistan, DRAP issued a product recall alert for fake Mirzpan Suspension. In the alert, DRAP […]